Insmed Incorporated

YTD

ALL

Trade Insmed Incorporated 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About INSM

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline.

CEO

William H. Lewis

CEOWilliam H. Lewis

Employees

1,664

Employees1,664

Headquarters

Bridgewater, New Jersey

HeadquartersBridgewater, New Jersey

Founded

1988

Founded1988

Employees

1,664

Employees1,664

INSM Key Statistics

Market cap

20.41B

Market cap20.41B

Price-Earnings ratio

-22.75

Price-Earnings ratio-22.75

Dividend yield

—

Dividend yield—

Average volume

2.72M

Average volume2.72M

High today

$95.00

High today$95.00

Low today

$92.63

Low today$92.63

Open price

$93.97

Open price$93.97

Volume

3.41M

Volume3.41M

52 Week high

$212.75

52 Week high$212.75

52 Week low

$90.39

52 Week low$90.39

Stock Snapshot

With a market cap of 20.41B, Insmed Incorporated(INSM) trades at $93.39. The stock has a price-to-earnings ratio of -22.75.

On 2026-10-26, Insmed Incorporated(INSM) stock moved within a range of $92.63 to $95.00. With shares now at $93.39, the stock is trading +0.8% above its intraday low and -1.7% below the session's peak.

Trading activity shows a volume of 3.41M, compared to an average daily volume of 2.72M.

Over the past 52 weeks, Insmed Incorporated(INSM) stock has traded between a high of $212.75 and a low of $90.39.

INSM News

Simply Wall St 2h

How Japan Launch Of BRINSUPRI At Insmed Has Changed Its Investment Story - Simply Wall Street

...

Simply Wall St 3d

Insmed Stock Looks About Right After Recent Pipeline Progress

has seen its share price swing sharply over recent years, and with fresh clinical and commercial updates landing, the question now is whether the current valuat...

TipRanks 5d

Insmed price target lowered to $213 from $218 at Morgan Stanley

Morgan Stanley lowered the firm’s price target on Insmed (INSM) to $213 from $218 and keeps an Overweight rating on the shares. Published first on TheFly – the...

Analyst ratings

96%

of 25 ratings

Buy

96%

Hold

Sell

More INSM News

Benzinga 5d

Top 3 Health Care Stocks That Could Blast Off In October

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a...

TipRanks 7d

Insmed announces commercial launch of brinsupri tablets in Japan

Insmed (INSM) announced the commercial launch in Japan of brinsupri tablets 25 mg, an oral, once-daily treatment for non-cystic fibrosis bronchiectasis in adult...

People also own

Based on the portfolios of people who own INSM. This list is generated using Robinhood data, and it’s not a recommendation.

Broadcom

Taiwan Semiconductor Manu…

Micron Technology

Oracle

Rocket Lab Corporation

Uber

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.